These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 8668380)
21. Polio vaccine: should New Zealand make the change? Baker C; Eberhart-Phillips J N Z Med J; 1997 Sep; 110(1051):340-2. PubMed ID: 9323376 [No Abstract] [Full Text] [Related]
22. Need for polio boosters after age two years. Rennels MB Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837 [No Abstract] [Full Text] [Related]
24. World wide experience with inactivated poliovirus vaccine. Bonnet MC; Dutta A Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777 [TBL] [Abstract][Full Text] [Related]
25. Polio vaccines: time for a change in immunisation policy? Beale AJ Lancet; 1990 Apr; 335(8693):839-42. PubMed ID: 1969568 [No Abstract] [Full Text] [Related]
26. Polio vaccine: what you should know. Salamone J J Pract Nurs; 1997 Mar; 47(1):14-5. PubMed ID: 9214969 [No Abstract] [Full Text] [Related]
27. Announcing sequential OPV-IPV schedule. Public Health Rep; 1996; 111(6):476-7. PubMed ID: 8955690 [No Abstract] [Full Text] [Related]
28. A more potent inactivated polio vaccine. Med Lett Drugs Ther; 1988 May; 30(765):50-1. PubMed ID: 3362093 [No Abstract] [Full Text] [Related]
29. Cost analysis of post-polio certification immunization policies. Sangrujee N; Cáceres VM; Cochi SL Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295 [TBL] [Abstract][Full Text] [Related]
30. A process evaluation of pulse polio immunization. Sokhey J; Atwood S; Andrus J; Suresh K; Banerjee K Indian Pediatr; 1996 Mar; 33(3):257-61. PubMed ID: 8772858 [No Abstract] [Full Text] [Related]
33. AAFP childhood immunization update. AAFP Commission on Clinical Policies and Research. Am Fam Physician; 1998 Jan; 57(1):158. PubMed ID: 9447221 [No Abstract] [Full Text] [Related]
34. The role of routine polio immunization in the post-certification era. Sutter RW; Cáceres VM; Mas Lago P Bull World Health Organ; 2004 Jan; 82(1):31-9. PubMed ID: 15106298 [TBL] [Abstract][Full Text] [Related]
35. [The perspective of global eradication of poliomyelitis]. Knolle H; Egli A; Candrian U Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784 [TBL] [Abstract][Full Text] [Related]
36. [Inactivated polio vaccine]. Pachón del Amo I Aten Primaria; 2004 Nov; 34(8):392-4. PubMed ID: 15546532 [No Abstract] [Full Text] [Related]
37. Paralytic poliomyelitis--United States, 1980-1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844 [TBL] [Abstract][Full Text] [Related]
38. [Poliomyelitis--why we must continue to vaccinate!]. Windorfer A; Beyrer K MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859 [TBL] [Abstract][Full Text] [Related]
39. [Prevention of poliomyelitis]. Schär M Ther Umsch; 1983 Mar; 40(3):206-8. PubMed ID: 6857558 [No Abstract] [Full Text] [Related]
40. [When is it necessary to renew Salk's polio vaccination?]. Spiess H Munch Med Wochenschr; 1970 Nov; 112(45):2056. PubMed ID: 5536286 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]